BridgeBio Pharma, Inc (BBIO) Stock Price

76.26 ▼ -1.64 (-2.11%)
Open: 75.01 Vol: 6.16M Day's range: 74.30 - 77.85 Jan 15, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
BBIO Technical Analysis
5 mins 30 mins Hourly Daily Weekly
NEUTRAL NEUTRAL NEUTRAL BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 76.56▼ 75.95▲ 76.01▲ 77.47▼ 76.77▼
MA10 76.55▼ 76.00▲ 76.66▼ 76.11▲ 73.91▲
MA20 76.19▲ 76.73▼ 77.60▼ 75.95▲ 64.41▲
MA50 75.95▲ 77.43▼ 75.70▲ 71.89▲ 49.30▲
MA100 76.51▼ 75.79▲ 75.94▲ 63.00▲ 38.51▲
MA200 77.49▼ 75.96▲ 74.98▲ 51.69▲ 28.02▲
  5 mins 30 mins Hourly Daily Weekly
MACD 0.020▲ -0.027▼ -0.316▼ -0.152▼ 0.646▲
RSI 52.019▲ 45.795▼ 46.410▼ 54.354▲ 77.220▲
STOCH 64.827     43.814     32.880     70.554     91.786▲
WILL %R -47.222     -56.688     -68.445     -40.537     -13.343▲
CCI -23.879     41.871     -43.405     19.631     67.858    
Latest Filters Detected On BBIO
MA $BBIO Price Crossed Below MA(7) Set Alert
▼ GAP $BBIO Open Gap Down %3 Set Alert
▼ GAP $BBIO Open Gap Down %2 Set Alert
BridgeBio Pharma, Inc News
BridgeBio Announces Commercial Progress, Program Updates, and 2026 Milestones at the 44th Annual J.P. Morgan Healthcare Conference
Wednesday, January 14, 2026 06:27 PM
Preliminary unaudited Q4 and Full Year 2025 net Attruby® product revenue of $146.0 million and $362.4 million, respectively - Attruby (acoramidis) is rapidly becoming the first-choice therapy for ...
BridgeBio Continues Long Term Debt Management Strategy and Announces Proposed Offering of Convertible Senior Notes due 2033 to Prefund Repayment of Convertible Senior Notes due ...
Wednesday, January 14, 2026 01:20 PM
The Company intends to use the net proceeds from the offering to repurchase, settle future conversion obligations in respect of or repay at maturity a portion of the Company’s 2.50% convertible senior ...
BridgeBio Pharma (BBIO) Gets a Buy from Raymond James
Wednesday, January 14, 2026 04:30 AM
Raymond James analyst Martin Auster reiterated a Buy rating on BridgeBio Pharma today and set a price target of $85.00. According to TipRanks, Auster is a 5-star analyst with an average return of 16.5 ...
BBIO historical stock data
date open high low close volume
15/01/26 75.01 77.85 74.30 76.26 6,164,752
14/01/26 79.28 79.31 76.8236 77.90 1,922,624
13/01/26 76.15 79.8799 75.07 79.11 2,595,719
12/01/26 76.78 77.41 70.95 76.84 5,081,260
09/01/26 74.48 78.36 74.46 77.25 2,889,389
08/01/26 73.55 75.49 73.05 73.82 1,754,958
07/01/26 74.13 75.57 72.89 74.27 2,340,017
06/01/26 73.69 74.29 71.19 73.99 3,363,022
05/01/26 78.29 78.585 71.99 73.42 3,029,810
02/01/26 76.54 78.54 76.02 78.235 2,413,539
Quote Details
52wk Low:28.325
52wk High:79.88
Vol:6.16M
Avg Vol(3m):37.6M
1Y Chng:+145.92%
1M Chng:+2.85%
Add to Watch List
More Information
Index US Composite
Market Cap. 15.01B